findmyKOL

Cindy Grines, MD

Enriched profile

Chief Scientific Officer, Northside Hospital Cardiovascular Institute · Northside Hospital

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Atlanta, GA · Southeast · United StatesSpecialtyCardiovascular DiseaseFocusCoronary Artery Disease / ACS
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Cindy Grines is Chief Scientific Officer, Northside Hospital Cardiovascular Institute at Northside Hospital. OpenAlex indexes 860 publications with 53,124 citations (h-index 101); ClinicalTrials.gov lists 2 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Cardiovascular Disease profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 14 Oct 2026

Cindy Grines, MD, is Chief Scientific Officer, Northside Hospital Cardiovascular Institute. The public record shows 860 publications with 53,124 citations (h-index 101), centered on Coronary Artery Disease / ACS. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 33 companies.

  • Most recent indexed publication: 2026 · Circulation
  • Top research focus: Coronary Artery Disease / ACS
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 33 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Coronary Artery Disease / ACS2 trialsCoronary Artery Disease1 trialMyocardial Infarction1 trialInfarction1 trialAcute Coronary Syndrome1 trial

Research focus

OpenAlex concept fingerprint
Coronary Artery Disease / ACS

Drugs & molecules

across trials, industry payments and publications
Leqviogeneric · InclisiranClinical trials—Industry payments19Publications1Xareltogeneric · RivaroxabanClinical trials—Industry payments21Publications—Repathageneric · EvolocumabClinical trials—Industry payments15Publications—Entrestogeneric · Sacubitril / valsartanClinical trials—Industry payments11Publications—Eliquisgeneric · ApixabanClinical trials—Industry payments10Publications—Vascepageneric · Icosapent ethylClinical trials—Industry payments7Publications—Vyndaqelgeneric · TafamidisClinical trials—Industry payments6Publications—Kerendiageneric · FinerenoneClinical trials—Industry payments5Publications—Farxigageneric · DapagliflozinClinical trials—Industry payments3Publications—Verquvogeneric · VericiguatClinical trials—Industry payments3Publications—Jardiancegeneric · EmpagliflozinClinical trials—Industry payments2Publications—Multaqgeneric · DronedaroneClinical trials—Industry payments2Publications—

Works with

trial sponsors and companies reporting payments
Novartis Pharmaceuticals CorporationClinical trials—Industry payments28Janssen Pharmaceuticals, IncClinical trials—Industry payments21Boston Scientific CorporationClinical trials—Industry payments20Amgen Inc.Clinical trials—Industry payments15Pfizer Inc.Clinical trials—Industry payments11Philips Electronics North America CorporationClinical trials—Industry payments10AbiomedClinical trials—Industry payments9Philips North America LLCClinical trials—Industry payments9Amarin Pharma Inc.Clinical trials—Industry payments7AstraZeneca Pharmaceuticals LPClinical trials—Industry payments5Bayer Healthcare Pharmaceuticals Inc.Clinical trials—Industry payments5E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments5Novo Nordisk ASClinical trials—Industry payments5Medtronic, Inc.Clinical trials—Industry payments4Novo Nordisk IncClinical trials—Industry payments4Abbott LaboratoriesClinical trials—Industry payments2Actelion Pharmaceuticals US, Inc.Clinical trials—Industry payments2Biotronik Inc.Clinical trials—Industry payments2Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments2Edwards Lifesciences CorporationClinical trials—Industry payments2Esperion Therapeutics, Inc.Clinical trials—Industry payments2Heartflow, Inc.Clinical trials—Industry payments2Merck Sharp & Dohme LLCClinical trials—Industry payments2Sanofi-Aventis U.S. LLCClinical trials—Industry payments2ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Clinical trials—Industry payments2Angel Medical SystemsClinical trials1Industry payments—Cardiva Medical, Inc.Clinical trials—Industry payments1Coloplast CorpClinical trials—Industry payments1Corewell Health EastClinical trials1Industry payments—CVRx, Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
860publications

Distinct works indexed by OpenAlex, matched via ORCID; 25 in PubMed.

53,124citations

Total citations across indexed works.

101h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials ↓
33companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 14 Oct 2026

33 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    86.6%
    Beta blocker17.8%
    Metoprolol Succinate42%Carvedilol26%Metoprolol Tartrate23%Labetalol Hcl5%Nebivolol Hcl5%
    Part D<11 patients
    Statin17.8%
    Atorvastatin Calcium45%Rosuvastatin Calcium43%Pravastatin Sodium7%Simvastatin5%
    Part D<11 patients

    + 11 more classes in this area

  • Blood & clotting

    9.9%
    Factor Xa inhibitor7.1%
    Eliquis85%Xarelto16%
    Part D<11 patients
    P2Y12 inhibitor2.8%
    Clopidogrel100%
    Part D≥24 patients
  • Metabolism & gastrointestinal

    3.4%
    SGLT2 inhibitor2.7%
    Jardiance63%Farxiga37%
    Part D<11 patients
    Potassium supplement0.7%
    Potassium Chloride100%
    Part D<11 patients
Where care is delivered (Part B)33.2% facility · 66.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/cindy-grines-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • X / Twitter

    x.com/DrCindyGrines

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗

Mentions by others

where others cite or feature them
  • Other

    northsidecvi.com/about-us/podcasts

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →northsidecvi.com ↗
  • Other

    radcliffecardiology.com/video-index/masterclass-smashing-glass-ceiling-dr-cindy-l-grines

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →radcliffecardiology.com ↗
  • X / Twitter

    x.com/Allison_Dupont/status/1294416364455763968

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Board Certified

    Cardiovascular Disease

    1987
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.northside.com ↗
  • Board Certified

    Internal Medicine

    1983
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.northside.com ↗
  • MD

    Ohio State University College of Medicine (Cum Laude)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →northsidecvi.com ↗
  • Internal Medicine Residency

    Ohio State University Hospital

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →northsidecvi.com ↗
  • Cardiovascular Disease Fellowship

    University of Michigan Hospital

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →northsidecvi.com ↗
  • Board Certified

    Interventional Cardiology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →northsidecvi.com ↗

Editorial & leadership roles

journal and society appointments
  • Past President

    Society for Cardiovascular Angiography and Interventions (SCAI)

    2020
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →northsidecvi.com ↗
  • Editor-in-Chief

    Journal of Interventional Cardiology (Wiley)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cardiovascularnews.com ↗
  • Fellow

    American College of Cardiology (FACC)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →northsidecvi.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.